Onconetix, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $-14.0M | $-58.7M | $-37.4M | $-13.4M | $-3.4M |
| Depreciation & Amortization | $15.2K | $731.3K | $43.9K | $6.8K | — |
| Depreciation | $15.0K | $22.0K | $7.0K | $6.8K | $4.9K |
| Amortization | — | $709.0K | $36.8K | — | — |
| Stock-Based Compensation | $74.3K | $438.7K | $329.8K | $2.0M | $130.1K |
| Net Cash from Operating Activities | $-9.7M | $-10.5M | $-13.6M | $-8.7M | $-2.0M |
| Investing Activities | |||||
| Capital Expenditures | — | $28.5K | $3.3K | $9.3K | $1.9K |
| Business Acquisitions | — | — | $-1.1M | — | — |
| Net Cash from Investing Activities | — | $-28.5K | $-8.6M | $-32.7K | $-1.9K |
| Financing Activities | |||||
| Dividends Paid | — | — | — | — | — |
| Stock Repurchases | — | — | — | $566.8K | — |
| Net Cash from Financing Activities | $14.5M | $6.7M | $1.0M | $32.5M | $-334.2K |
| Net Change in Cash | $4.6M | $-3.9M | $-21.2M | $23.8M | — |
| Free Cash Flow | — | $-10.5M | $-13.6M | $-8.7M | $-2.0M |